In lab research, Saint Louis University scientists limit autistic behavior

December 02, 2015

ST. LOUIS -- In a study published this week in ACS Chemical Neuroscience, Saint Louis University researchers report that treating mice with a compound, SR1078, reduces autistic behavior. The drug, developed by Thomas Burris, Ph.D., chair of pharmacology and physiology at SLU, and his lab, increases the expression of genes that are known to be low in the brains of autistic patients.

Autism spectrum disorder is a group of neurodevelopmental disorders that include difficulty with social interaction, communication and excessive repetitive behaviors. Currently, though there are medications available to treat some symptoms, no drug therapies exist that treat the underlying disorder itself.

While scientists don't fully understand the causes of autism, studies have demonstrated that certain genes tend to be low (underexpressed) in the brains of autistic children. RORa, a nuclear receptor, is also low in the brains of those with autism. An activator of gene expression, RORa has been shown to regulate the key genes that are underexpressed in autistic brains.

Burris's team developed a drug, SR1078, that increases the activity of RORa, and, subsequently, increases expression of the missing genes.

"We developed the first drugs that can target RORa effectively. SR1078 is, at this point, more of compound than a true drug. It will have to be optimized before it is ready for human testing," Burris said. "However, it is able to reach the brain, and that is a key factor."

Burris's group used a particular strain of mouse that displays autistic behavior and in this mouse model, animals display behavior such as overgrooming, fixation on inanimate objects and social deficits.

"Mice groom themselves constantly. We use videotape and count their grooming events. A normal mouse will groom itself around 125 times in 10 minutes. Mice with an autistic profile will groom themselves 250 times in that span due to excessive repetitive behavior."

When these mice were treated with the drug compound, Burris found both increased expression of the missing genes and reduced autistic behavior, with a significant decrease in repetitive grooming events.

Additionally, studies with human brain cells in culture also showed that the drug increases the expression of these genes, as well.

Next, the research team will study the mice's social activity and see what impact the drug has on this aspect of their behavior.

The research is in early stages and much more study will need to be completed, including clinical trials in humans, before it could be used as a therapy for children with autism. However, the research team is encouraged by their progress in a field that currently offers very few pharmacological options for those on the autism spectrum.

"There's such a paucity of autism therapies," Burris said. "There's not much out there, and approved drugs are antipsychotic compounds that treat symptoms.

"We are aiming to modulate genes that were dysregulated by the disorder. We hope this will be the start of developing therapies that will get closer to aiming at a root cause."
-end-
This research was funded by the National Institutes of Health (MH092769).

Other researchers on the study include Yongjun Wang, Cyrielle Billon and John K. Walker.

Established in 1836, Saint Louis University School of Medicine has the distinction of awarding the first medical degree west of the Mississippi River. The school educates physicians and biomedical scientists, conducts medical research, and provides health care on a local, national and international level. Research at the school seeks new cures and treatments in five key areas: cancer, liver disease, heart/lung disease, aging and brain disease, and infectious diseases.

Saint Louis University

Related Autism Articles from Brightsurf:

Autism-cholesterol link
Study identifies genetic link between cholesterol alterations and autism.

National Autism Indicators Report: the connection between autism and financial hardship
A.J. Drexel Autism Institute released the 2020 National Autism Indicators Report highlighting the financial challenges facing households of children with autism spectrum disorder (ASD), including higher levels of poverty, material hardship and medical expenses.

Autism risk estimated at 3 to 5% for children whose parents have a sibling with autism
Roughly 3 to 5% of children with an aunt or uncle with autism spectrum disorder (ASD) can also be expected to have ASD, compared to about 1.5% of children in the general population, according to a study funded by the National Institutes of Health.

Adulthood with autism
The independence that comes with growing up can be scary for any teenager, but for young adults with autism spectrum disorder and their caregivers, the transition from adolescence to adulthood can seem particularly daunting.

Brain protein mutation from child with autism causes autism-like behavioral change in mice
A de novo gene mutation that encodes a brain protein in a child with autism has been placed into the brains of mice.

Autism and theory of mind
Theory of mind, or the ability to represent other people's minds as distinct from one's own, can be difficult for people with autism.

Potential biomarker for autism
A study of young children with autism spectrum disorder published in JNeurosci reveals altered brain waves compared to typically developing children during a motor control task.

Autism often associated with multiple new mutations
Most autism cases are in families with no previous history of the disorder.

State laws requiring autism coverage by private insurers led to increases in autism care
A new study led by researchers at the Johns Hopkins Bloomberg School of Public Health has found that the enactment of state laws mandating coverage of autism spectrum disorder (ASD) was followed by sizable increases in insurer-covered ASD care and associated spending.

Autism's gender patterns
Having one child with autism is a well-known risk factor for having another one with the same disorder, but whether and how a sibling's gender influences this risk has remained largely unknown.

Read More: Autism News and Autism Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.